Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren for Aortic Stiffness in Marfan Syndrome
NCT01715207Phase 3Completed
- Sponsor
- Samsung Medical Center
- Start
- Jun 2010
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aliskiren in Marfan syndrome (MFS), sponsored by Samsung Medical Center. Started Jun 2010; status: completed.
02
Drugs
aliskiren
03
Conditions
Marfan syndrome (MFS)
Beyond the preview
Go deeper on NCT01715207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01715207.